logo
Share SHARE
FONT-SIZE Plus   Neg

CTI BioPharma Gets $10 Mln Milestone Payment For TRISENOX From Teva

CTI BioPharma Corp. (CTIC) announced Thursday that it has received a $10 million milestone payment from Teva Pharmaceutical Industries Ltd. (TEVA) related to the achievement of sales milestones for TRISENOX (arsenic trioxide).

TRISENOX was acquired from CTI BioPharma by Cephalon, Inc., which was subsequently acquired by Teva.

The company noted that the milestone was paid pursuant to an acquisition agreement for TRISENOX entered into with Cephalon under which CTI BioPharma is eligible to receive up to an additional $60 million in payments upon achievement by Teva of specified sales and development milestones related to TRISENOX.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
While Democrats have largely been critical of the Republican tax reform plan, President Donald Trump has claimed the proposal has some bipartisan support. Trump suggested to reporters ahead of a meeting with members of the Senate Finance Committee on Wednesday that "people on both sides" support the tax reform plan. Healthcare is very expensive in the U.S., in fact among the most expensive in the world by most measures. Health care facilities are largely owned and operated by businesses in the private sector. Most Americans have access to health care, though costs and services vary from state to state. However,... Electronic Arts Inc. said it is shutting down its Visceral Games Studio and making major changes to its upcoming Star Wars project currently being developed by the studio. Visceral Games is best known for creating the "Dead Space" series.
comments powered by Disqus
Follow RTT